Clavis Pharma: Clinical Trials

1 trial sponsored by Clavis Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Clavis Pharma: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
Elacytarabine, Investigator's Choice - Acute Myeloid Leukemia (AML)
Phase 3CompletedClavis Pharma3812010-06-012013-09-27

Conditions studied

Leukemia, Myeloid, Acute (1)

Interventions

5'-oleoyl cytarabine (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Norway (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

David Rizzieri, MD (1)  ·  Francis J Giles, MD, PhD (1)

Results publications

PMID 24841975